A teenager in California died from an overdose after spending months asking ChatGPT, an artificial intelligence chatbot, about drug use and so-called “safe” dosages. He had friends. He studied psychology. He liked video games. According to his mother, the clearest signs of anxiety and depression didn’t show up in his social life, but they appeared… Keep Reading
From pleasure and connection to harm reduction and policy failure, a look at what decades of drug enforcement got wrong about human behavior. The conversation around drugs has long been framed by cost. Policymakers calculate the billions lost every year to productivity gaps, hospitalizations, law enforcement and incarceration. The U.S. alone spends an estimated $193 billion… Keep Reading
Editor’s Note: High Times has long supported the removal of cannabis from Schedule I and ultimately federal descheduling. The following guest column reflects the legal analysis of the author and examines what current rescheduling efforts do (and do not) mean for today’s cannabis operators. By Jason W. Klimek, partner and cannabis industry team co-leader at… Keep Reading
In recent weeks, media outlets from Fox 8 to CNN have turned up the volume on stories about Cannabinoid Hyperemesis Syndrome (CHS), a rare but very real condition tied to chronic cannabis use. The coverage is loud, graphic, and alarmist. What it isn’t? Balanced. Let’s be clear: CHS exists. It’s a documented medical syndrome involving… Keep Reading
Colorado’s Natural Medicine Program is moving from legislation to lived practice, built not by corporations but by the people preparing to guide patients through psychedelic care. Colorado is trying to do something no state has ever succeeded at: create a regulated, statewide psychedelic care system from scratch. Not decriminalization-only. Not theoretical. A real, clinically governed… Keep Reading
A new survey from the Center for Drug Tourism Studies at UERJ (State University of Rio de Janeiro) shows that cannabis-focused fairs and festivals continue to expand across Brazil — with notable growth in the Northeast region. Events such as Festival Diamba in Paraíba and the Febre de Arte fair in Fortaleza are helping drive… Keep Reading
“We are being erased,” asserts American writer Bruce Wagner, but he’s far from sensationalism, even breathing a certain amount of relief. His latest book, The Marvel Universe: Origin Stories, weaves fables of broken characters and updates his biting, satirical take on the world of entertainment, bringing it into the era of social media. Raised in… Keep Reading
In recent years, ketamine has emerged as a favorite drug in various corners, from tech bros to raves, to medicine. Indeed, more and more people are opting for ketamine therapy for mental health, but its use without medical supervision can lead to addiction, and even death. That’s exactly what’s happening in the United Kingdom, a… Keep Reading
Entirely by chance, my father is buried just a few rows away from Levi Strauss, the man whose name is synonymous with denim and one of the most enduring clothing brands in American history. For decades, whenever I went to the cemetery just outside San Francisco, I’d quickly pause to say hello to Mr. Strauss.… Keep Reading
AI isn’t coming to cannabis; it’s already here. From automated grow rooms to predictive inventory systems and compliance bots, cannabis is quietly entering its most advanced era ever. And just like legalization, the tech revolution won’t wait for anyone. The global artificial intelligence market reached $196.63 billion in 2023 and is projected to grow at… Keep Reading
